16^th World Hematology Congress

Matthew Frome is Senior Manager of Business Development at Thermo Fisher Scientific. He brings over 20 years of industry experience. Most recently, he was VP of Business Development at Linkage Biosciences (acquired by Thermo Fisher Scientific in 2018), and Director of Business Development at Solazyme. Before Solazyme, author founded Focus Biology, a start-up bioinformatics company. Prior to Focus, he held various roles of increasing responsibility at GE Healthcare (Amersham Biosciences/Molecular Dynamics), Sangamo Biosciences, Applied Biosystems and Sungene Technologies. He received an MBA and Masters of Public Health from the University of California, Berkeley and a MS in Biology from Stanford University.